
    
      The ABC/ TridentÂ® study was initiated in 1996 as an FDA IDE pre-market study in the United
      States for alumina bearing THR. PreMarket Approval (PMA)application was approved in February
      3,2003. The Post Approval Study (PAS) involved six surgeon investigators from the original
      IDE study. Subjects who consented to participate in the Post Approval Study continued to be
      followed to collect limited patient reported data regarding status of the hip.
    
  